Loading viewer...
investor_presentation
Format: PDF investor_presentation
Aadi Bioscience Inc. is a biopharmaceutical company focused on developing and commercializing innovative product candidates, including FYARRO (nab-sirolimus, ABI-009). This June 2021 corporate overview presents Aadi's business strategy, clinical development programs, and proposed merger with Aerpio. The presentation outlines the company's research pipeline and commercial prospects in oncology and related therapeutic areas.
presentation
CenterPoint Energy
investor_presentation
R1 RCM
investor_presentation
Macroblock